I imagine the US has a ton of leverage in such negotiations. Something along the lines of "give us a good price on this to make us look good or else maybe we'll actually do something about the ridiculous price gouging for medicine in this country."
No pharma exec wants to be the one that killed the golden goose.
No pharma exec wants to be the one that killed the golden goose.